drugset / Trial / NCT00967499

Pilot Study to Assess Palonosetron Versus Ondansetron as Rescue Medication in Subjects That Develop Postoperative Nausea and Vomiting (PONV) in the Postanesthesia Care Unit (PACU)

NCT00967499

Phase 2 Completed 239 enrolled Eisai Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate palonosetron versus ondansetron as rescue medication in subjects that develop postoperative nausea and vomiting (PONV) in the Postanaesthesia Care Unit (PACU).

Timeline

Start
2009-07-13
Primary completion
2009-12-18
Completion
2009-12-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ondansetron Other / unclassified 4 mg Intravenous
Comparator Palonosetron Other / unclassified 0.075 mg Intravenous

Indications

No indication recorded.